Nutahara K, Higashihara E
Department of Urology, Kyorin University, School of Medicine.
Nihon Rinsho. 1995 Apr;53(4):953-7.
There are several reports of an increased occurrence of nonparathyroid cancer in patients with primary hyperparathyroidism. Whether there is a cause and effect relationship has not been established. Especially, the coexistence of the parathyroid and thyroid tumors appears significantly high. Recently PRAD 1 was determined the one of the oncogenes of parathyroid adenoma. Interest in PRAD 1's role with respect to oncogenesis has been intensified by its incrimination in other, nonparathyroid, human tumors. If properly conducted surveillance programs do indicate a higher likelihood of cancer in patients with primary hyperparathyroidism, the current philosophy that the patient with mild and asymptomatic hyperparathyroidism does not need the surgery must be reevaluated.
有几份报告指出,原发性甲状旁腺功能亢进患者中非甲状旁腺癌的发生率有所增加。因果关系尚未确立。特别是,甲状旁腺肿瘤和甲状腺肿瘤同时存在的情况似乎明显偏高。最近,PRAD 1被确定为甲状旁腺腺瘤的致癌基因之一。由于它在其他非甲状旁腺人类肿瘤中的牵连,人们对PRAD 1在肿瘤发生中的作用的兴趣更加浓厚。如果适当开展的监测项目确实表明原发性甲状旁腺功能亢进患者患癌的可能性更高,那么目前认为轻度无症状甲状旁腺功能亢进患者不需要手术的观念就必须重新评估。